Official Title
Remote Monitoring in Patients With Coronavirus Disease (COVID-19)
Brief Summary

The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting.

Detailed Description

The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting. This study will enroll COVID-19 positive patients previously evaluated at Mount Sinai Hospital/Mount Sinai Health System (MSHS) and affiliated hospitals deemed appropriate for home monitoring. Patients will be monitored remotely in the outpatient setting for 1-3 weeks following diagnosis and/or treatment for COVID-19 at MSH/MSHS.

Not yet recruiting
COVID-19
Cardiac Arrhythmias

Diagnostic Test: VitalConnect Vital Sign Patch
This patch provides continuous real-time monitoring of cardiac telemetry, heart rate, respiratory rate and oxygen saturation. Duration of monitoring is typically up to 7 days.
This patch is applied to the upper left side of the chest wall, attached with a hypoallergenic adhesive material. (This device is FDA approved for this indication).
Vital Connect Patch Arm

Eligibility Criteria

Inclusion Criteria:

- Patients diagnosed with coronavirus and determined to be eligible for home monitoring and self-care, and either 1. Not admitted to the hospital, and permitted to recover at home 2. Discharged from inpatient hospitalization, during the acute recovery period

- 18 years old or older with the ability to understand the requirements of the study and sign the informed consent form (or able to provide over-the-phone verbal consent).

Exclusion Criteria:

N/A

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years
Countries
United States
Locations

Icahn School of Medicine at Mount Sinai
New York, New York, 10029

Investigator: Betsy Ellsworth, ANP
Contact: 212-824-8902
betsy.ellsworth@mountsinai.org


Investigator: Sam Cammack, MA, MPH
Contact: 212-824-8931
sam.cammack@mountsinai.org

Investigator: Vivek Y Reddy, MD

Contacts

Sam Cammack
212-824-8931
sam.cammack@mountsinai.org

Betsy Ellsworth, ANP
212-824-8902
betsy.ellsworth@mountsinai.org

Vivek Y Reddy, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai

~

Martin Goldman, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai

NCT Number
Keywords
Covid-19
Cardiac Arrhythmias
Atrial Fibrillation
Telemetry
MeSH Terms
Arrhythmias, Cardiac